Search

METHOTREXATE BELLON 5 MG / 2 ML, Solution injectable (Retiré du marché)

Details

--- Description
Pack 1 flacon de 1 ml
Strength (Dosage)
Laboratory MAPHAR
Ingredients Méthotrexate
Therapeutic class Antinéoplasique, antimétabolite (antifolique)
ATC code L01BA01
PPH $1.32
PPV $2.12
Refundable No
Refund base $0.00
Refund rate $0.00
Table A
Marketing status Commercialized
Type Not specified
Uses - Traitement de néoplasies hématologiques comme la leucémie lymphatique aiguë et myéloïde et le lymphome non hodgkinien ainsi que de tumeurs solides telles que cancer du sein, carcinome bronchique, tumeurs malignes de la tête et du cou, ostéosarcome, choriocarcinome et autres tumeurs trophoblastiques, cancer de la vessie.
- Traitement de maladies auto-immunes telles que la polyarthrite rhumatoïde.
- Traitement du psoriasis sévère non maîtrisé, résistant au traitement classique.
Warnings
Dosage
Avoid
Side effects
Interactions

Medications with one or more of the ingredients above


Medications under one or more of the therapeutic classes above


Medications from the same laboratory


Disclaimer
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.